33558-75-7 Usage
Description
ALLYL(CHLOROMETHYL)DIMETHYLSILANE is an organosilicon compound that serves as a versatile intermediate in the synthesis of various organic compounds, including α-silyl alcohols, ethers, and amines. Its unique structure allows for a wide range of applications in different industries.
Uses
Used in Chemical Synthesis:
ALLYL(CHLOROMETHYL)DIMETHYLSILANE is used as a synthetic intermediate for the preparation of α-silyl alcohols, ethers, and amines. Its reactivity and stability make it a valuable compound in the chemical industry for creating a variety of organic molecules with diverse applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, ALLYL(CHLOROMETHYL)DIMETHYLSILANE is used as a key building block for the development of new drugs and therapeutic agents. Its ability to form α-silyl alcohols, ethers, and amines allows for the creation of novel molecular structures with potential medicinal properties.
Used in Material Science:
In the field of material science, ALLYL(CHLOROMETHYL)DIMETHYLSILANE is utilized as a precursor for the synthesis of advanced materials with unique properties. These materials can be used in various applications, such as coatings, adhesives, and sealants, due to their enhanced performance characteristics.
Used in Electronics Industry:
The electronics industry also benefits from the use of ALLYL(CHLOROMETHYL)DIMETHYLSILANE as it can be employed in the development of new materials with improved electrical and thermal properties. These materials can be used in the manufacturing of electronic components, such as semiconductors and insulators, to enhance their performance and reliability.
Check Digit Verification of cas no
The CAS Registry Mumber 33558-75-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,5,5 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 33558-75:
(7*3)+(6*3)+(5*5)+(4*5)+(3*8)+(2*7)+(1*5)=127
127 % 10 = 7
So 33558-75-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H13ClSi/c1-4-5-8(2,3)6-7/h4H,1,5-6H2,2-3H3
33558-75-7Relevant articles and documents
Cyclizations of 2-(Allyldimethylsilyl)ethyl Radicals
Saigo, Kazuhide,Tateishi, Kazuo,Adachi, Hiroshi,Saotome, Yasushi
, p. 1572 - 1574 (1988)
-
Conformational analysis of 3,3-dimethyl-3-silathiane, 2,3,3-trimethyl-3- silathiane and 2-trimethylsilyl-3,3-dimethyl-3-silathiane-preferred conformers, barriers to ring inversion and substituent effects
Kirpichenko, Svetlana V.,Kleinpeter, Erich,Shainyan, Bagrat A.
supporting information; scheme or table, p. 859 - 865 (2011/05/06)
The first conformational analysis of 3-silathiane and its C-substituted derivatives, namely, 3,3-dimethyl-3-silathiane 1, 2,3,3-trimethyl-3-silathiane 2, and 2-trimethylsilyl-3,3-dimethyl-3-silathiane 3 was performed by using dynamic NMR spectroscopy and B3LYP/6-311G(d,p) quantum chemical calculations. From coalescence temperatures, ring inversion barriers δG≠ for 1 and 2 were estimated to be 6.3 and 6.8 kcal/mol, respectively. These values are considerably lower than that of thiacyclohexane (9.4 kcal/mol) but slightly higher than the one of 1,1-dimethylsilacyclohexane (5.5 kcal/mol). The conformational free energy for the methyl group in 2 (-°G0 - 0.35 kcal/mol) derived from low-temperature13C NMR data is fairly consistent with the calculated value. For compound 2, theoretical calculations give δE value close to zero for the equilibrium between the 2-Me ax and 2-Meeq conformers. The calculated equatorial preference of the trimethylsilyl group in 3 is much more pronounced (-δG0 - 1.8 kcal/mol) and the predominance of the 3-SiMe 3 eq conformer at room temperature was confirmed by the simulated1H NMR and 2D NOESY spectra. The effect of the 2-substituent on the structural parameters of 2 and 3 is discussed. Copyright
N-derivatives of 1-deoxy nojirimycin
-
, (2008/06/13)
This invention relates to novel N-derivatives of 1-deoxy nojirimycin, to the method for their preparation and to their use in the treatment of diabetes and the use against retro-viruses, particularly in the treatment of acquired immuno-deficiency syndrome